Patent classifications
C07D233/72
Compounds
The present invention provides compounds of the formula (I) and their use as Kv3 modulators. ##STR00001##
Compounds
The present invention provides compounds of the formula (I) and their use as Kv3 modulators. ##STR00001##
Heterocyclic amide compounds having an RORvt inhibitory action
The present invention relates to compound (I) or a salt thereof which has a RORt inhibitory action. In the formula (I), each symbol is as defined in the specification. ##STR00001##
Heterocyclic amide compounds having an RORvt inhibitory action
The present invention relates to compound (I) or a salt thereof which has a RORt inhibitory action. In the formula (I), each symbol is as defined in the specification. ##STR00001##
Hydantoin containing deoxyuridine triphosphatase inhibitors
Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
Nitrogen ring linked deoxyuridine triphosphatase inhibitors
Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
Nitrogen ring linked deoxyuridine triphosphatase inhibitors
Provided herein are dUTPase inhibitors, compositions comprising such compounds and methods of using such compounds and compositions.
Hydantoin derivative compounds, methods of use and methods of treatment
The present disclosure provides compositions including a hydantoin derivative compound, pharmaceutical compositions including a hydantoin derivative compound, methods of treatment of a condition (e.g., bacterial infection) or disease, methods of treatment using compositions or pharmaceutical compositions, and the like.
Hydantoin derivative compounds, methods of use and methods of treatment
The present disclosure provides compositions including a hydantoin derivative compound, pharmaceutical compositions including a hydantoin derivative compound, methods of treatment of a condition (e.g., bacterial infection) or disease, methods of treatment using compositions or pharmaceutical compositions, and the like.
HETEROCYCLIC COMPOUNDS AS HIV PROTEASE INHIBITORS
The present invention is directed to compounds of Formula I, pharmaceutical compositions comprising the same, and their use in the inhibition of HIV protease, the inhibition of HIV replication, the prophylaxis of infection by HIV, the treatment of infection by HIV, and the prophylaxis, treatment, and delay in the onset or progression of AIDS.
##STR00001##